27628070|t|Clinical heterogeneity of LRRK2 p.I2012T mutation
27628070|a|Leucine-rich repeat kinase 2 (LRRK2) mutations are the most common genetic cause of Parkinson's disease (PD). However, only few cases carrying LRRK2 mutations have been reported in Taiwanese PD patients. We used targeted next generation sequencing (NGS), covering 24 candidate genes involved in neurodegenerative disorders, to analyze 40 probands with familial PD, and 10 patients with mixed neurodegenerative disorders. Sanger sequencing of the identified mutation in the first set of the study was performed in additional 270 PD patients, including 139 familial PD and 131 early-onset PD (onset age less than 50 years old), and 300 age/gender matched control subjects. We found a missense variant, p.I2012T, in the LRRK2 gene in one sporadic patient having early-onset frontotemporal dementia with parkinsonism and dystonia. Sanger sequencing this substitution in additional 270 PD patients in the second set of the study revealed two additional variant carriers: one having autosomal-dominant familial PD, and one with sporadic PD. The p.I2012T substitution was absent in 300 normal control subjects. Analyzing family members of the proband with p.I2012T revealed co-segregation of the variant and parkinsonism. Clinical presentations, levodopa responses, and (Tc99m)TRODAT - SPECT imaging findings of this index family were similar to idiopathic PD. Our results revealed clinical heterogeneity of the LRRK2 p.I2012T substitution, and demonstrated the use of targeted NGS for genetic diagnosis in multiplex families with PD or mixed neurodegenerative disorders.
27628070	0	22	Clinical heterogeneity	T033	C1837514
27628070	26	40	LRRK2 p.I2012T	T028	C1425650
27628070	41	49	mutation	T045	C0026882
27628070	50	78	Leucine-rich repeat kinase 2	T028	C1425650
27628070	80	85	LRRK2	T028	C1425650
27628070	87	96	mutations	T045	C0026882
27628070	117	124	genetic	T169	C0314603
27628070	134	153	Parkinson's disease	T047	C0030567
27628070	155	157	PD	T047	C0030567
27628070	193	198	LRRK2	T028	C1425650
27628070	199	208	mutations	T045	C0026882
27628070	231	240	Taiwanese	T098	C1556096
27628070	241	243	PD	T047	C0030567
27628070	244	252	patients	T101	C0030705
27628070	262	270	targeted	T169	C1521840
27628070	271	297	next generation sequencing	T063	C2936622
27628070	299	302	NGS	T063	C2936622
27628070	317	332	candidate genes	T028	C1332838
27628070	345	372	neurodegenerative disorders	T047	C0524851
27628070	388	396	probands	T032	C0702111
27628070	402	413	familial PD	T047	C0030567
27628070	422	430	patients	T101	C0030705
27628070	442	469	neurodegenerative disorders	T047	C0524851
27628070	471	488	Sanger sequencing	T063	C1511897
27628070	507	515	mutation	T045	C0026882
27628070	578	580	PD	T047	C0030567
27628070	581	589	patients	T101	C0030705
27628070	605	616	familial PD	T047	C0030567
27628070	625	636	early-onset	T033	C1833334
27628070	637	639	PD	T047	C0030567
27628070	641	650	onset age	T081	C0206132
27628070	703	719	control subjects	T096	C0009932
27628070	732	748	missense variant	T045	C0599155
27628070	750	758	p.I2012T	T028	C0017337
27628070	767	777	LRRK2 gene	T028	C1425650
27628070	785	793	sporadic	T079	C0205422
27628070	794	801	patient	T101	C0030705
27628070	809	820	early-onset	T033	C1833334
27628070	821	844	frontotemporal dementia	T047	C0338451
27628070	850	862	parkinsonism	T047	C0242422
27628070	867	875	dystonia	T184	C0013421
27628070	877	894	Sanger sequencing	T063	C1511897
27628070	900	912	substitution	T052	C1706204
27628070	931	933	PD	T047	C0030567
27628070	934	942	patients	T101	C0030705
27628070	998	1005	variant	T028	C0678941
27628070	1006	1014	carriers	T033	C0007294
27628070	1027	1057	autosomal-dominant familial PD	T047	C0030567
27628070	1072	1083	sporadic PD	T047	C0030567
27628070	1089	1097	p.I2012T	T028	C0017337
27628070	1098	1110	substitution	T052	C1706204
27628070	1115	1121	absent	T169	C0332197
27628070	1129	1152	normal control subjects	T096	C0009932
27628070	1164	1178	family members	T099	C0086282
27628070	1186	1193	proband	T032	C0702111
27628070	1199	1207	p.I2012T	T028	C0017337
27628070	1217	1231	co-segregation	T169	C0205245
27628070	1239	1246	variant	T033	C4284334
27628070	1251	1263	parkinsonism	T047	C0242422
27628070	1265	1273	Clinical	T080	C0205210
27628070	1274	1287	presentations	T078	C0449450
27628070	1289	1297	levodopa	T116,T121,T123	C0023570
27628070	1298	1307	responses	T040	C0683154
27628070	1313	1326	(Tc99m)TRODAT	T109,T121	C0535449
27628070	1343	1351	findings	T169	C2607943
27628070	1360	1372	index family	T099	C0015576
27628070	1389	1402	idiopathic PD	T047	C0030567
27628070	1425	1447	clinical heterogeneity	T033	C1837514
27628070	1455	1469	LRRK2 p.I2012T	T028	C1425650
27628070	1470	1482	substitution	T052	C1706204
27628070	1512	1520	targeted	T169	C1521840
27628070	1521	1524	NGS	T063	C2936622
27628070	1529	1546	genetic diagnosis	T060	C0596612
27628070	1550	1568	multiplex families	T099	C0015576
27628070	1574	1576	PD	T047	C0030567
27628070	1580	1585	mixed	T169	C0205430
27628070	1586	1613	neurodegenerative disorders	T047	C0524851